Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Inhaled tuberculosis vaccine more effective than traditional shot

Abstract:
A novel aerosol version of the most common tuberculosis (TB) vaccine, administered directly to the lungs as an oral mist, offers significantly better protection against the disease in experimental animals than a comparable dose of the traditional injected vaccine, researchers report this week in the Proceedings of the National Academy of Sciences.

Inhaled tuberculosis vaccine more effective than traditional shot

Cambridge, MA | Posted on March 12th, 2008

The aerosol vaccine -- under development through a collaboration between Harvard University and the international not-for-profit Medicine in Need (MEND) -- could provide a low-cost, needle-free TB treatment that is highly stable at room temperature.

"Rising rates of tuberculosis and drug-resistant disease in developing countries have amply illustrated the need for more effective vaccines," says David Edwards, the Gordon McKay Professor of the Practice of Biomedical Engineering in Harvard's School of Engineering and Applied Sciences. "While most new TB vaccines continue to call for needle injection, our vaccine could provide safer, more consistent protection by eliminating these injections and the need for refrigerated storage. We see great promise for this new treatment."

Says Barry R. Bloom, dean of the Harvard School of Public Health: "Tuberculosis is one of the most resistant and challenging diseases to protect against, and the successful results of aerosol delivery using nanoparticle technology offers a potentially new platform for immunization. Were the animal results here confirmed in human studies, this technology could be used not only for TB vaccines, but those protecting against other infectious diseases as well."

The current PNAS paper by Edwards, Bloom, and colleagues at the University of North Carolina-Chapel Hill, the Aeras Global TB Vaccine Foundation, MEND South Africa, the Harvard School of Public Health and School of Engineering and Applied Sciences, and Manta is based on studies involving guinea pigs, a species of rodent highly sensitive to TB.

Among guinea pigs vaccinated with the aerosol treatment and subsequently exposed to TB, less than 1 percent of lung and spleen tissue showed effects of the disease. By contrast, in animals treated with the same dose of the traditional injected vaccine, some 5 percent of lung tissue and 10 percent of spleen tissue showed symptoms following TB exposure.

Administered to 100 million infants annually, the current Bacillus Calmette-Guérin (BCG) vaccine for TB is the world's most widely administered childhood vaccine. Dried into a powder by freezing and delivered by needle injection, the vaccine requires refrigerated storage and has shown variable degrees of protection against tuberculosis in different parts of the world. These limitations have prompted calls from public health experts and physicians for alternative treatments.

The rapid-drying process by which the aerosol vaccine is made resembles the technique used in the manufacture of powdered milk. In the aerosol vaccine, particles form at micrometer and nanometer scales and in spherical and elongated shapes, a combination that appears to improve dispersal in the mouth.

While commonly used with food, cosmetics, and pharmaceuticals, this spray drying of small and large molecules is seldom used for drying cellular material. The new technique enables TB vaccines, and potentially other bacterial and viral-based vaccines, to sidestep the traditional problems associated with keeping vaccines chilled.

"Spray drying is lower-cost than BCG, easily scalable for manufacturing, and ideal for needle-free use, such as via inhalation," says Edwards, an international leader in aerosol drug and vaccine delivery. "Its greater stability at room temperature could ultimately provide a better means of creating and delivering vaccine throughout the world."

Edwards and Bloom's co-authors are Anthony Hickey, Lucila Garcia-Contreras, Pavan Muttil, and Danielle Padilla, all of UNC-Chapel Hill; Yun-Ling Wong, Jessica DeRousse, and Katharina Elbert of Harvard's School of Engineering and Applied Sciences; Jerry Sadoff of the Aeras Global TB Vaccine Foundation; Willem Andreas Germishuizen and Bernard Fourie of MEND South Africa; Sunali Goonesekera of the Harvard School of Public Health; and Rich Miller of Manta. The research was supported by a Grand Challenge Grant from the Bill and Melinda Gates Foundation.

####

For more information, please click here

Contacts:
Steve Bradt

617-496-8070

Copyright © Harvard University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Optimized method to detect high-dimensional entanglement December 3rd, 2021

Scientists edge closer to probe that would inspect atherosclerotic plaques by forcing molecules to sound their presence December 3rd, 2021

Two-dimensional bipolar magnetic semiconductors with high Curie-temperature and electrically controllable spin polarization realized in exfoliated Cr(pyrazine)2 monolayers December 3rd, 2021

Review on the femtosecond laser precision micro/nano-engineering December 3rd, 2021

Nanomedicine

Scientists edge closer to probe that would inspect atherosclerotic plaques by forcing molecules to sound their presence December 3rd, 2021

Immune system-stimulating nanoparticle could lead to more powerful vaccines: The potent new adjuvant could be used to help make vaccines against HIV and other infectious diseases December 3rd, 2021

Scientists develop promising vaccine method against recurrent UTI November 19th, 2021

Cancer cells use ‘tiny tentacles’ to suppress the immune system: With the power of nanotechnology, investigators have discovered that cancer cells strengthen by forming nanotubes that they use to suck mitochondria out of immune cells November 19th, 2021

Discoveries

Researchers develop polyimide-mica nanocomposite film with high resistance to low earth orbit environments December 3rd, 2021

Researchers realize ultra-high precision search for exotic interactions December 3rd, 2021

Optimized method to detect high-dimensional entanglement December 3rd, 2021

Scientists edge closer to probe that would inspect atherosclerotic plaques by forcing molecules to sound their presence December 3rd, 2021

Announcements

Scientists edge closer to probe that would inspect atherosclerotic plaques by forcing molecules to sound their presence December 3rd, 2021

Two-dimensional bipolar magnetic semiconductors with high Curie-temperature and electrically controllable spin polarization realized in exfoliated Cr(pyrazine)2 monolayers December 3rd, 2021

Review on the femtosecond laser precision micro/nano-engineering December 3rd, 2021

Development of a single-process platform for the manufacture of graphene quantum dots: Precisely controls the bonding configuration of heteroatoms in graphene quantum dots through simple chemical processes. Practical application and commercialization in various fields is expected December 3rd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project